Advanced bioengineering technologies for preclinical research

Fecha de publicación

2020-09-01T08:27:15Z

2020-09-01T08:27:15Z

2019-06-25

2020-09-01T08:27:16Z

Resumen

Current in vitro practices must overcome important challenges to compare favorably with human studies. The limited applicability of conventional in vitro assays and strategies can be explained by the fact that standard approaches do not enable recapitulation of the complexity of human tissues and physiological functions. To address this challenge, novel bioengineering tools, techniques and technologies are rapidly emerging to advance current fundamental knowledge and innovate in vitro practices. For example, organs-on-a-chip have recently appeared as a small-scale solution to overcome the transability, financial and ethical concerns associated with animal studies in drug discovery and development. In parallel, biomimetic interfaces are increasingly recapitulating 3D structures with tissue-like dynamic properties to allow in-depth investigation of disease mechanisms. This review aims at highlighting current bioengineering approaches poised to address the shortcomings of conventional in vitro research practices towards the generation of more effective solutions for improving human health.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Materias y palabras clave

Bioenginyeria; Biosensors; Bioengineering; Biosensors

Publicado por

Taylor and Francis

Documentos relacionados

Reproducció del document publicat a: https://doi.org/10.1080/23746149.2019.1622451

Advances in Physics: X, 2019, vol. 4, num. 1, p. 423-450

https://doi.org/10.1080/23746149.2019.1622451

info:eu-repo/grantAgreement/EC/H2020/647863/EU//COMIET

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

cc-by (c) Martínez Fraiz, Elena et al., 2019

http://creativecommons.org/licenses/by/3.0/es